The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Macular Edema From Central Retinal Vein Occlusion
Abstract
Abstract. To determine whether bevacizumab could improve visual acuity and optical coherence tomography outcomes in a patient with macular edema from central retinal vein occlusion, an intravitreal injection of bevacizumab (1.0 mg) was given. Prior intravitreal injections of triamcinolone acetonide resulted in vision improvement but worsening cataract and borderline glaucoma. Wthin 1 week of the bevacizumab injection, visual acuity improved from 20/200 to 20/50 and optical coherence tomography revealed resolution of the cystic maculopathy. The improvements were maintained for at least 4 weeks. Intravitreal injections of bevacizumab may provide another treatment option for patients with macular edema from vein occlusions. [Ophthalmic Surg Lasers Imaging 2005;36:336-339.]
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion
Greenberg, P. B. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.2.247 · Cited by 370
Park, C. H., Jaffe, G. J., & Fekrat, S. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00228-9 · Cited by 219
Ip, M. S. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.8.1131 · Cited by 186
Williamson, T. H., & O’Donnell, A. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.01.001 · Cited by 102
Krepler, K., Ergun, E., Sacu, S., Richter-Müksch, S., Wagner, J., Stur, M., & Wedrich, A. (2005) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2005.00400.x · Cited by 42
Ip, M., & Kumar, K. (2003) · Retina · doi:10.1097/00006982-200306000-00051 · Cited by 17
New Therapy for Central Retinal Vein Occlusion: Are Intravitreal Steroids a Possible Answer?
Blumenkranz, M. S. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.2.259 · Cited by 7
Cited by
Diabetic Macular Edema: Pathogenesis and Treatment
Bhagat, N., Grigorian, R. A., Tutela, A., & Zarbin, M. A. (2009) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2008.10.001 · Cited by 571
Fung, A. E., Rosenfeld, P. J., & Reichel, E. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.099598 · Cited by 532
Self-citationSPAIDE, R. F., & FISHER, Y. L. (2006) · Retina · doi:10.1097/00006982-200603000-00004 · Cited by 507
Wu, L., Martínez-Castellanos, M. A., Quiroz-Mercado, H., Arevalo, J. F., Berrocal, M. H., Farah, M. E., Maia, M., Roca, J. A., Rodriguez, F. J., & for the Pan American Collaborative Retina Group (PACORES) (2007) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0660-z · Cited by 456
INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS
PEYMAN, G. A., LAD, E. M., & MOSHFEGHI, D. M. (2009) · Retina · doi:10.1097/iae.0b013e3181a94f01 · Cited by 255
Metadata
- Authors
- Rosenfeld, P. J., Fung, A. E., & Puliafito, C. A.
- Venue
- Ophthalmic Surgery, Lasers and Imaging Retina
- Publisher
- SLACK, Inc.
- Published
- 2005-07
- Volume
- 36
- Issue
- 4
- Pages
- 336-339
- ISSN
- 1542-8877 (ISSN-L)
- 2325-8160
- 2325-8179
- OpenAlex
- W4297917733
- Cited by
- 489
- References
- 8
- FWCI
- 48.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Macular Edema From Central Retinal Vein Occlusion. https://app.cochat.ai/papers/10.3928/1542-8877-20050701-15
- The paper
- Rosenfeld, P. J., Fung, A. E., & Puliafito, C. A. (2005). Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Macular Edema From Central Retinal Vein Occlusion. Ophthalmic Surgery, Lasers and Imaging Retina. https://doi.org/10.3928/1542-8877-20050701-15
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.